z-logo
open-access-imgOpen Access
A New PAMPA Model Proposed on the Basis of a Synthetic Phospholipid Membrane
Author(s) -
Hui Yu,
Qi Wang,
Ying Sun,
Ming Shen,
Ling He,
Yourong Duan
Publication year - 2015
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0116502
Subject(s) - phospholipid , basis (linear algebra) , membrane , computational biology , chemistry , biophysics , biology , biochemistry , mathematics , geometry
The purpose of this work was to investigate the synthetic phospholipid dependence of permeability measured by parallel artificial membrane permeability assay (PAMPA) method. Three phospholipids with hydrophobic groups of different lengths and phosphorylcholine as the hydrophilic group were concisely synthesized. Ten model drug molecules were selected because of their distinct human fraction absorbed (%FA) values and various pK a characteristics. In vitro drug permeation experiments were designed to determine the effect of the incubation time (4–20 h), pH gradient (4.6–9.32) and carbon chain length (8, 10, 12) on the drug permeability through the synthetic phospholipid membrane in the PAMPA system. The results showed that intensive and significant synthetic phospholipids dependence of permeability influenced by the length of lipid’s hydrophobic carbon chain. The effective permeability constant ( P e ) of each drug increased rapidly with time, then decreased slightly after reaching the maximum; the pH gradient changed the drug permeability according to the pH-partition hypothesis for drugs with diverse pK a values; and longer hydrophobic chains in the synthetic phospholipid membrane improved the drug permeability, as observed for all test drugs at almost all incubation time points. This newly proposed PAMPA model considered the synthetic phospholipid membrane and showed good P e -%FA correlation for the passive transport of drugs, making it a helpful supplementary method for PAMPA systems.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here